Results 131 to 140 of about 7,107 (213)

Multiple modes of AFM reveal distinct mechanical properties for dystrophin and utrophin not manifest by small fragments. [PDF]

Proc Natl Acad Sci U S A
Hua C, Vavra J, Powers J, Muretta JM, Ervasti JM, Salapaka MV.   +5 more
europepmc   +1 more source

Emerging roles of microRNAs and other non-coding transcriptome in muscular dystrophies. [PDF]

Inflamm Regen
Abdelrehim FG, Sadek Z, Fahim SA, El-Ekiaby N, Abdelaziz AI, Fawzy IO.   +5 more
europepmc   +1 more source

Foxi1 regulates multipotent mucociliary progenitors and ionocyte specification through transcriptional and epigenetic mechanisms. [PDF]

PLoS Biol
Bowden S, Brislinger-Engelhardt MM, Hansen M, Andricek A, Temporal-Plo A, Weber D, Hägele S, Lorenz F, Litwin T, Kreutz C, Walentek P.   +10 more
europepmc   +1 more source

Genetic strategies for therapy of Duchenne muscular dystrophy. [PDF]

Mol Ther Nucleic Acids
Łoboda A, Chamberlain JS, Dulak J.
europepmc   +1 more source

Functional role of downstream utrophin enhancer for utrophin expression in the skeletal muscle

Functional role of downstream utrophin enhancer for utrophin expression in the skeletal muscle
博士論文要旨
openaire  

Obestatin treatment links mitochondrial homeostasis and skeletal muscle repair in Duchenne muscle dystrophy. [PDF]

Mol Biomed
Lodeiro AC, Costas-Abalde S, Cid-Díaz T, Debasa-Corral L, Leal-López S, Mamchaoui K, Mouly V, Casabiell X, Gallego R, Relova JL, Pazos Y, Santos-Zas I, Camiña JP.   +12 more
europepmc   +1 more source

Inflammation in a severe model of dystrophic cardiomyopathy contains a high proportion of T cells that contribute to onset of pathology. [PDF]

Am J Physiol Heart Circ Physiol
Piepho AB, Krishna S, Sturgill SL, Lowe J, Wolfe Z, Pomeranets RM, Walmiki S, Rosenzweig R, Howard ZM, Ziolo MT, Oestreich KJ, Rafael-Fortney JA.   +11 more
europepmc   +1 more source

Transcytotic transportation of size-controlled nanocarriers into dystrophic skeletal muscle leads to therapeutic outcome in mice. [PDF]

Nat Commun
Liu X, Hicks MR, Feng Z, Jiang J, Li Y, Young CS, Zhang T, Saleh K, Emami MR, Liu Y, Qin M, Li J, Zheng Y, Yang H, Spencer MJ, Pyle AD, Meng H.   +16 more
europepmc   +1 more source

MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration. [PDF]

EMBO Mol Med
Sowa N, Horie T, Ide Y, Baba O, Kora K, Yoshida T, Nakamura Y, Matsumura S, Matsushita K, Imanaka M, Zou F, Kume E, Kojima H, Qian Q, Kimura K, Otsuka R, Hara N, Yamasaki T, Otani C, Tsujisaka Y, Takaya T, Nishimura C, Watanabe D, Hasegawa K, Kotera J, Oka K, Fujita R, Takemiya A, Sasaki T, Kasahara Y, Obika S, Kimura T, Ono K.   +32 more
europepmc   +1 more source

Micro-utrophin Therapy for Duchenne Muscular Dystrophy [PDF]

Molecular Therapy, 2019
openaire   +2 more sources